Business Of Biotech cover image

Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

Business Of Biotech

00:00

Pivot to radiotherapeutics and rationale

Marc recounts Sitori's transformation into Plus Therapeutics and the strategic shift from cell therapy to CNS radiotherapeutics.

Play episode from 08:09
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app